JPH0255954A - Multilayered analysis element - Google Patents
Multilayered analysis elementInfo
- Publication number
- JPH0255954A JPH0255954A JP20728288A JP20728288A JPH0255954A JP H0255954 A JPH0255954 A JP H0255954A JP 20728288 A JP20728288 A JP 20728288A JP 20728288 A JP20728288 A JP 20728288A JP H0255954 A JPH0255954 A JP H0255954A
- Authority
- JP
- Japan
- Prior art keywords
- layer
- group
- denotes
- formula
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004458 analytical method Methods 0.000 title abstract description 5
- 229920001577 copolymer Polymers 0.000 claims abstract description 42
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 40
- 239000012530 fluid Substances 0.000 claims abstract description 16
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims description 5
- 239000000523 sample Substances 0.000 abstract description 12
- 238000005259 measurement Methods 0.000 abstract description 4
- 239000012472 biological sample Substances 0.000 abstract description 2
- -1 poly(N-vinylpyrrolidone) Polymers 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 238000000576 coating method Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010089254 Cholesterol oxidase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920005596 polymer binder Polymers 0.000 description 2
- 239000002491 polymer binding agent Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- BJEWLOAZFAGNPE-UHFFFAOYSA-N 1-ethenylsulfonylethane Chemical compound CCS(=O)(=O)C=C BJEWLOAZFAGNPE-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 1
- 229920001747 Cellulose diacetate Polymers 0.000 description 1
- 108010077078 Creatinase Proteins 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- AJZOEKAQKCTUDY-UHFFFAOYSA-N OP(O)(=O)OC1=C(Br)C=CC2=C1C=CN2 Chemical compound OP(O)(=O)OC1=C(Br)C=CC2=C1C=CN2 AJZOEKAQKCTUDY-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010060059 Sarcosine Oxidase Proteins 0.000 description 1
- 102000008118 Sarcosine oxidase Human genes 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 102000000019 Sterol Esterase Human genes 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000007765 extrusion coating Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- GKQWYZBANWAFMQ-UHFFFAOYSA-M lithium;2-hydroxypropanoate Chemical compound [Li+].CC(O)C([O-])=O GKQWYZBANWAFMQ-UHFFFAOYSA-M 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- URXNVXOMQQCBHS-UHFFFAOYSA-N naphthalene;sodium Chemical compound [Na].C1=CC=CC2=CC=CC=C21 URXNVXOMQQCBHS-UHFFFAOYSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- YPNZYYWORCABPU-UHFFFAOYSA-N oxiran-2-ylmethyl 2-methylprop-2-enoate;styrene Chemical compound C=CC1=CC=CC=C1.CC(=C)C(=O)OCC1CO1 YPNZYYWORCABPU-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- ZKOWFAZDOLZUJK-UHFFFAOYSA-N phthalic acid;azide Chemical compound [N-]=[N+]=[N-].OC(=O)C1=CC=CC=C1C(O)=O ZKOWFAZDOLZUJK-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 229940074439 potassium sodium tartrate Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野」
本発明は、流体試料中の特定成分を分析するための分析
素子に関し、更に詳しくは生物学的試料中の特定成分を
分析するための多層分析素子に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to an analytical element for analyzing a specific component in a fluid sample, and more particularly to a multilayer element for analyzing a specific component in a biological sample. Regarding analytical elements.
生物学的流体試料中の特定成分を分析する九めの多層型
乾式の分析素子は種々の構成のものが知られている。そ
れらの中で、試薬層と多孔性展開層の間にポリ(N−ビ
ニルピロリドン)、ポリ(N−イングロビルアクリルア
ミド)等の重合体から成る中間層を設けて、試薬層と多
孔性展開層との接着性を向上させる方法が、例えば特公
昭5B−19062号公報、特開昭50−157192
号、同52−131786号、同53−24893号、
同54−26795号、同60−256068号各公報
、特願昭61−197569号明細書等の実施例中に記
載されている。Various configurations of multilayer dry analytical elements for analyzing specific components in biological fluid samples are known. Among them, an intermediate layer made of a polymer such as poly(N-vinylpyrrolidone) or poly(N-inglobil acrylamide) is provided between the reagent layer and the porous development layer, and the reagent layer and the porous development layer are Methods for improving the adhesiveness with
No. 52-131786, No. 53-24893,
It is described in Examples of Japanese Patent Application No. 54-26795, No. 60-256068, Japanese Patent Application No. 197569/1980, etc.
上記のような重合体から成る中間層の塗設け、確かに試
薬層と多孔性展開層の間の接着性の向上にかなシ効果は
あるが、それでも多層分析素子(スライド)を作成する
ため、小片に断裁する際には、試薬層と多孔性展開層の
間ではく離が認められ、接着性としてはまだ充分満足で
きるものとは言い難く、更なる改善が望まれている。Coating the intermediate layer made of a polymer as described above certainly has a certain effect on improving the adhesion between the reagent layer and the porous spreading layer, but still, in order to create a multilayer analytical element (slide), When cutting into small pieces, peeling was observed between the reagent layer and the porous spreading layer, and the adhesion was still far from satisfactory, and further improvement is desired.
本発明の目的は、試薬層と多孔性展開層の間の接着性が
者しく改善され、かつそれに伴って測定積度(同時再現
性)も大幅に改善された多層分析素子を提供することに
ある。An object of the present invention is to provide a multilayer analytical element in which the adhesion between the reagent layer and the porous spreading layer is significantly improved, and the measurement volume (simultaneous reproducibility) is also significantly improved accordingly. be.
本発明を概説すれば、本発明は多141分析素子に関す
る発明であって、支持体上に試薬層及びその上方に多孔
性展開層を有する流体試料中の特定成分を分析するため
の多層分析素子において、下記一般式!及びlI:
〔式中曳R1は低級アルキル基、Xは20〜95モル%
、7は5〜80モル%なる数を示す」〔式中、R1は水
素原子又はメチル基、R,rjフェニル基、シアン基又
は式−00014,で表わされる一M5<式中R4は低
級アルキル基を示す)、xI rl、50〜95モA/
%、y、d!5〜soモル俤なる数を示す〕
で表わされる共重合体よシなる群から選択し九少なくと
も1種の共重合体を、前記多孔性展開層、及び前記試薬
層と前記多孔性展開層との間のノーに含有していること
を特徴とする。To summarize the present invention, the present invention relates to a multilayer analytical element for analyzing a specific component in a fluid sample, which has a reagent layer on a support and a porous spreading layer above the reagent layer. In, the following general formula! and lI: [in the formula, R1 is a lower alkyl group, X is 20 to 95 mol%
, 7 represents a number of 5 to 80 mol%" [wherein R1 is a hydrogen atom or a methyl group, R, rj phenyl group, cyan group, or -00014, -M5<wherein R4 is lower alkyl group), xI rl, 50-95 moA/
%,y,d! At least one copolymer selected from the group consisting of copolymers represented by: It is characterized by containing between no.
以下、本発明全具体的に説明する。Hereinafter, the present invention will be fully explained in detail.
本発明において測定し得る流体試料中の特定成分として
は、例えばグルコース((flu) 、総コレステロー
ル(T−choL−モグロビン(Hb)、 アルブミン
(Alt+)、総タンパク(TP)、尿酸(Uム)、総
ビリルビン(T−Eil)、クレアチニン(OR)、
グルタミン酸オキザロ酢酸トランスアミナーゼ(GO
T)、グルタミン!1!ピルビンぼトランスアミナーゼ
(GPT)、乳酸脱水素酵素(LDi()、γ−グルタ
ミルトランスペプチダーゼ(y−GTP)、アルカリホ
スファターゼ(ALP)、アミラーゼ(ムMY)等線々
の成分が挙げら几る。Specific components in a fluid sample that can be measured in the present invention include, for example, glucose ((flu), total cholesterol (T-choL-moglobin (Hb), albumin (Alt+), total protein (TP), and uric acid (Um)). , total bilirubin (T-Eil), creatinine (OR),
Glutamate oxaloacetate transaminase (GO
T), glutamine! 1! The components include pyrubimbo transaminase (GPT), lactate dehydrogenase (LDi), γ-glutamyl transpeptidase (y-GTP), alkaline phosphatase (ALP), and amylase (MY).
本発明に係る試薬層には、流体試料中の特定成分と直接
的又は間接的に関与する試薬を含有し、こnらの試薬と
しては色素形成前駆物質、酵素、補酵素、緩衝剤、必要
に応じて基質等が包含される。The reagent layer according to the present invention contains reagents that directly or indirectly interact with specific components in the fluid sample, and these reagents include pigment-forming precursors, enzymes, coenzymes, buffers, and necessary components. Substrates and the like are included depending on the situation.
本発明に係る試薬層に含有される試薬としては、例えば
C11uを測定する4h会は、4−アミノアンチビリ7
.1.7−シヒドロキシナフタレン、グルコースオキシ
ダーゼ(GOD)、ペルオキシダーゼ(POD)、リン
酸塩バッファー等を、T−Ch。As a reagent contained in the reagent layer according to the present invention, for example, the 4h group for measuring C11u is 4-aminoantiviral 7
.. 1.7-hydroxynaphthalene, glucose oxidase (GOD), peroxidase (POD), phosphate buffer, etc., with T-Ch.
の場合は、4−了ミノアンチピリン、1,7−ジヒドロ
ヤシナフタレン、POD、 9ン酸m−<ツファー等
1、nb の場合は、アジ化ナトリウム、亜硝酸ナトリ
ウム、トリスバッファー等を、Albの場合は、クエ/
ばバッファー等を、TPO場合は、硫酸鋼、酒石酸カリ
ウムナトリウム、水酸化ナトリウム等t’、Uムの場合
は、カブラウリカーゼ、POD、ホウ酸塩バッファー等
を、T−Bilの場合は、ジアゾニウム塩、重合体酸物
質等を、ORの場合は、クレアチニンアミドヒドロラー
ゼ、クレアチンアミジノヒドロラーゼ、ザルコシンオキ
シダーゼ、カブラ−POD 、グツドバッファー等を、
GO’l’の場合は、グルタミン酸脱水素酵素(GID
H)、 ジアホラーゼ、テトラゾリウム化合物、トリス
バッファー等を、GPT O場合は、GIDH、ジアホ
ラーゼ、テトラゾリウム化合物、トリスバッファー等を
、LDHの場合は、テトラゾリウム化合物、トリスバッ
ファー等を、γ−GTPO場合は、グリシルグリシン、
塩化マグネシウム、トリスバッファー等を、ALPの場
合は、テトラゾリウム化合物、トリスバッファー等を、
OPKの場合は、ジアホラーゼ、テトラゾリウム化合物
、グツドバッファー等ji、AMYの場合は、p−ニト
ロフェニルマルトへブタオシド、α−グルコシダーゼ、
グツドバッファー等が挙げられる。上記試薬層には、ま
た他の付加的な添加剤として、列えば保恒剤、界面活性
剤等、種々の添加剤も所望に応じて添加することができ
る。In the case of 1, nb, add sodium azide, sodium nitrite, Tris buffer, etc. to Alb. In case, query/
For TPO, use steel sulfate, potassium sodium tartrate, sodium hydroxide, etc. For Um, use cablauricase, POD, borate buffer, etc. For T-Bil, use diazonium salt. , polymeric acid substances, etc., and in the case of OR, creatinine amide hydrolase, creatine amidinohydrolase, sarcosine oxidase, Kabra-POD, Gud buffer, etc.
In the case of GO'l', glutamate dehydrogenase (GID
H) Diaphorase, a tetrazolium compound, Tris buffer, etc. are used for GPT O, GIDH, diaphorase, a tetrazolium compound, Tris buffer, etc. are used for LDH, and a tetrazolium compound, Tris buffer, etc. are used for γ-GTPO. Silglycine,
Magnesium chloride, Tris buffer, etc., in the case of ALP, tetrazolium compound, Tris buffer, etc.
In the case of OPK, diaphorase, tetrazolium compound, gut buffer, etc., in the case of AMY, p-nitrophenylmaltohebutaoside, α-glucosidase,
Examples include good buffer. Various other additives, such as preservatives and surfactants, can also be added to the reagent layer as desired.
本発明において測定し得る流体試料中の特定成分は上記
のものに限定されるものではなく、上記以外の種々の成
分に対しても適も可能であシ、また試薬層に含有される
試薬も上記のものに限定されるものではなく、成分の種
類あるいは同じ成分であっても異なる分析反応を用いる
場合は、上記の試薬類似外のものら用いることができる
。The specific components in the fluid sample that can be measured in the present invention are not limited to those mentioned above, and various components other than those mentioned above may also be used. The reagents are not limited to those described above, and when using different types of components or different analytical reactions even for the same components, reagents other than those similar to those described above can be used.
上記試薬層は水浴性ポリマー又ri親水性かつ有機溶媒
可溶性のポリマーを−くインダーとして支持体上に塗布
することによって層として設けることができる。水溶性
ポリマー・(インダーとしてはゼラチン、フタル化ゼラ
チン等のゼラチンfJj導体、Mドロキシエチルセルロ
ース、カルボキシメチルセルロースナトリウム塩等の水
溶性セルロースd導体、ポリビニルアルコール、ポリ(
N−ビニルピロリドン)、ポリアクリルアミド、ポリメ
タクリルアミド、アクリルアミドとアクリル酸エステル
の共電合体、ポリ(モノ又はジアルキル置換)アクリル
アミド、ポリ(モノ又はジアルキル置換)メタクリルア
ミド及びこれらの水溶性共重合体等が挙げられ、好まし
くはゼラチン、ポリアクリルアミド及びアクリルアミド
とアクリル酸エステルの共重合体が用いられる。親水性
かつ有機溶媒可溶性ポリマーバインダーとしては、ポリ
(N−ビニルピロリドン)、ポリ(N−ビニルイミダゾ
ール)、ポリ(N−ビニルトリ了ゾール)及びこnらの
誘導体又はそれらの共電合体、エチルセルロース、メチ
ルセルロース等のセルロースd導に等が挙げられる。こ
nらのポリマー・(インダーは主としてアルコール類、
例えばエタノール、グロパノール、ブタノール等に溶解
し且つ親水性の高分子物質である。The above-mentioned reagent layer can be provided as a layer by coating a water-bathable polymer or a hydrophilic and organic solvent-soluble polymer as an inder onto the support. Water-soluble polymers (inders include gelatin, gelatin fJj conductors such as phthalated gelatin, water-soluble cellulose d conductors such as M droxyethyl cellulose and carboxymethyl cellulose sodium salt, polyvinyl alcohol, poly(
N-vinylpyrrolidone), polyacrylamide, polymethacrylamide, coelectrolyte of acrylamide and acrylic acid ester, poly(mono- or dialkyl-substituted) acrylamide, poly(mono- or dialkyl-substituted) methacrylamide, and water-soluble copolymers thereof, etc. Preferably, gelatin, polyacrylamide, and a copolymer of acrylamide and acrylic ester are used. Examples of the hydrophilic and organic solvent-soluble polymer binder include poly(N-vinylpyrrolidone), poly(N-vinylimidazole), poly(N-vinylimidazole) and their derivatives or coelectrolytes thereof, ethyl cellulose, Examples include cellulose d-conductors such as methylcellulose. These polymers (inders are mainly alcohols,
For example, it is a hydrophilic polymeric substance that dissolves in ethanol, gropanol, butanol, etc.
上記ポリマーバインダーは、選ばれる特定成分及びその
分析反応によって任意に選ぶことができる。また、選ば
れる分析反応が2種以上の試薬から構成されている場合
、この試薬を同一試薬層内に一緒に混合して含有させて
も、また、2種以上の試薬を2つ又はそれ以上の別々の
試薬層として含有させてもよい。こnらは分析反応自体
の作用憬構によって決定δ几ることもあシ、好ましくな
い影響を及ばさない限シにおいて、その構成は任意であ
る。The above polymer binder can be arbitrarily selected depending on the specific component selected and its analytical reaction. Furthermore, if the analytical reaction chosen is composed of two or more reagents, it is also possible to contain two or more reagents mixed together in the same reagent layer. may be contained as separate reagent layers. These components may be determined depending on the working structure of the analytical reaction itself, but their configuration is arbitrary as long as they do not have undesirable effects.
上記試薬層の膜厚は所望に応じて任意に選択することが
可能であるが、好ましくは1〜200μm%更に好まし
くは5〜100μmである。The thickness of the reagent layer can be arbitrarily selected as desired, but is preferably 1 to 200 μm%, and more preferably 5 to 100 μm.
本発明に係る多孔性展開層は、(1)一定容量の流体試
料を単位面積当り試薬層に均一に配布する機能を有する
ものでるる。その上、更に、特公昭55−21677号
公報に記載された性能、すなわ’& (2)流体試料中
の分析反応を阻害する物質又は要因を除去する機能及び
/又rit33分光光度分析を行うときに支持体を経て
透過する測定光を反射するパックグランド作用を行う機
能を有するものであれば好ましい。したがって、本発明
に係る多孔性展開層は、上記(1)のdA能のみを有す
る層、(1)に加えて田)及び/又は(3)の機能を併
せて有する層のいずれかとすることができ、あるいは(
1)を包含する複数の機能を適宜分離し、各機能ごとに
別の層を使用することら可能である。更に(11、(2
)及び(3)の機能のうち、2つの機能を有する層と、
残シの1つの機能を有する層を組合せて使用することも
できる。列えば、前述の特公昭55−21677号公報
に記載された二酸化チタン及び二酢酸セルロースから成
るプラッシュポリマーと呼称される非繊維多孔質媒体の
展開層、特開昭55−164556号明細書に記載され
た親水化処理した織物の展開層、特開昭57−9465
8号、同57−125847号、同57−197466
号及び同58−70161号等の各明細書に記載された
繊維分散液塗布による展開層、特開昭513−9016
7号明細書に記載された粒子結合体構造展開層が挙げら
れる。特に、上記繊維分散液塗布による展開層及び粒子
結合体構造展開層は、血球部分も速やかに移送すること
が可能な素材として特に有用である。本発明の多層分析
素子における展開層の膜厚は、その空隙率によって決定
されるべきであるが、好ましくは約100〜600μm
1 更に好ましくは約150〜400μmである。また
、空隙率は好ましくは約20〜85僑である。The porous spreading layer according to the present invention has the function of (1) uniformly distributing a fixed volume of fluid sample to the reagent layer per unit area; In addition, it further performs the performance described in Japanese Patent Publication No. 55-21677, that is, (2) the function of removing substances or factors that inhibit analytical reactions in fluid samples and/or performing RIT33 spectrophotometric analysis. It is preferable that it has the function of performing a pack-ground effect of reflecting the measurement light that sometimes passes through the support. Therefore, the porous spreading layer according to the present invention may be either a layer having only the dA function described in (1) above, or a layer having the functions of (1) and/or (3) in addition to (1). or (
It is possible to appropriately separate a plurality of functions including 1) and use a separate layer for each function. Furthermore, (11, (2
) and (3), a layer having two functions;
It is also possible to use a combination of layers having one of the remaining functions. For example, the spread layer of a non-fibrous porous medium called a plush polymer consisting of titanium dioxide and cellulose diacetate, which is described in the above-mentioned Japanese Patent Publication No. 55-21677; Developed layer of hydrophilized fabric, JP-A-57-9465
No. 8, No. 57-125847, No. 57-197466
JP-A No. 513-9016, a spreading layer formed by applying a fiber dispersion as described in the specifications of No. 58-70161, etc.
Examples include the particle combination structure development layer described in No. 7 specification. In particular, the spreading layer and particle aggregate structure spreading layer formed by coating the fiber dispersion are particularly useful as materials that can quickly transport blood cell portions. The thickness of the developing layer in the multilayer analytical element of the present invention should be determined by its porosity, but is preferably about 100 to 600 μm.
1 More preferably about 150 to 400 μm. Further, the porosity is preferably about 20 to 85%.
上記多孔性展開層には、選ばれる特定成分及びその分析
反応によっては、前述の試薬層の場合と同様、流体試料
中の特定成分と直接的又は間接的に関与する試薬を含有
することができる。Depending on the specific component selected and its analytical reaction, the porous spreading layer can contain a reagent that directly or indirectly interacts with the specific component in the fluid sample, as in the case of the reagent layer described above. .
例えば、T−Ohoを測定する場合は、コレステロール
エステラーゼ(coI!i)、コレステロールオキシダ
ーゼ(COD)等を、Albの場合は、ブロムクレゾー
ルグリーン等を、Uムの場合は、水素供与体等を、T−
Bilの場合は、ダイフィリン等を、QOT (D場合
は、−−アスパラギン酸ナトリウム、α−ケトグルタル
酸、ニコチンアミドアデニンジヌクレオチド(!aAD
”) 等(eSGPTの場合は、L−アラニン、α−
ケトグルタル酸、1IAD+ 等を、LDH(D場合は
、乳酸リチウム、MAD+ ジアホラーゼ等を、 A
LPの場合は、5−ブロモ−4−インドリルリン酸、硫
酸マグネシウム等を、OPKの場合は、クレアチンリン
酸、ADP、グルコース−6−リン酸、脱水素酵素、ヘ
キソキナーゼ、グルコース、1jAD+等を、r−G’
rPの場合は、r−グルタミル−p−ニトロアニリド等
が挙げられる。For example, when measuring T-Oho, cholesterol esterase (coI!i), cholesterol oxidase (COD), etc. are used, for Alb, bromcresol green, etc., for Um, hydrogen donor, etc. T-
In the case of Bil, dyphyllin, etc. are administered to QOT (in the case of D, - sodium aspartate, α-ketoglutarate, nicotinamide adenine dinucleotide (!aAD
”) etc. (in the case of eSGPT, L-alanine, α-
Ketoglutaric acid, 1IAD+, etc., LDH (D, lithium lactate, MAD+ diaphorase, etc.,
For LP, use 5-bromo-4-indolyl phosphate, magnesium sulfate, etc. For OPK, use creatine phosphate, ADP, glucose-6-phosphate, dehydrogenase, hexokinase, glucose, 1jAD+, etc. , r-G'
In the case of rP, examples include r-glutamyl-p-nitroanilide.
これらは−列でらシ、特定成分の種類あるいは上記と同
じ特定成分であっても異なる分析反応を用いる場合は、
上記の試薬類以外のものも含有することができる。These are in the - column. If the type of specific component or the same specific component as above but a different analytical reaction is used,
Reagents other than those mentioned above may also be contained.
また他の付加的な添加剤として、例えば保恒剤、界面活
性剤等、種々の添加剤も所望に応じて添加することがで
きる。Furthermore, various other additives such as preservatives and surfactants may be added as desired.
特に界面活性剤は、流体試料を本発明の素子に適用した
際の浸透速度の調節等有効に用いることができる。In particular, surfactants can be effectively used to adjust the permeation rate when a fluid sample is applied to the element of the present invention.
使用可能な界面活性剤としては、イオン性(アニオン性
又はカチオン性)、非イオン性を問わず使用することが
可能であるが、非イオン性界面活性剤が有効である。非
イオン性界面活性剤の例としては、例えば2.5−ジー
t−ブテルフエノキシボリエテレングリコール、p−オ
クチルフエノキシボリエテレングリコール、p−イソノ
ニルフェノキシポリエチレングリコール等のアルキル#
換フェノールのポリアルキレングリコール誘導体、高級
脂肪酸のポリアルキレ/グリコールエステルなどが挙げ
られる。これらの界面活性剤は流体試料の試薬層への浸
透速度を調節し、同時に好ましからざる「クロマトグラ
フィー現象」発生を抑制する効果を有する。As usable surfactants, both ionic (anionic or cationic) and nonionic surfactants can be used, but nonionic surfactants are effective. Examples of nonionic surfactants include alkyl surfactants such as 2,5-di-t-buterphenoxybolyetelene glycol, p-octylphenoxybolyeterene glycol, and p-isononylphenoxypolyethylene glycol.
Examples include polyalkylene glycol derivatives of converted phenols and polyalkylene/glycol esters of higher fatty acids. These surfactants have the effect of regulating the rate of penetration of the fluid sample into the reagent layer and at the same time suppressing the occurrence of undesirable "chromatographic phenomena."
上記界面活性剤は広範に選択さnた量を用いることが可
能であるが、塗布液の重量に対して25IILk%〜0
.005鱈0、好ましくは15重量暢〜α05重t%用
いることができる。The above-mentioned surfactant can be used in a widely selected amount, but may range from 25IILk% to 0% by weight based on the weight of the coating solution.
.. 005 cod 0, preferably 15% by weight to α05% by weight can be used.
本発明に係る共重合体としては、前記一般式(1)及び
/又d(II)で示さnる共重合体を用いることができ
る。As the copolymer according to the present invention, a copolymer represented by the general formula (1) and/or d(II) can be used.
以下に本発明に係る共重合体の代表的な具体例を示すが
、これによって本発明が限定されるものではない。Typical specific examples of the copolymer according to the present invention are shown below, but the present invention is not limited thereto.
内示共重合体
(1111−ビニルピロリドン−酢酸ビニル共重合体(
モル比95:5)
(2)N−ビニルピロリドン−酢酸ビニル共重合体(モ
ル比80 : 20 )
(3)N−ビニルピロリドン−酢酸ビニル共重合体(モ
ル比70 : 50 )
(4)N−ビニルピロリドン−酢酸ビニル共重合体(モ
ル比60 : 40 )
(51kl−ビニルピロリドン−酢酸ビニル共重合体(
モル比50 : 50 ’)
(6)N−ビニルピロリドン−酢酸ビニル共重合体(モ
ル比40 : 60 )
(力 N−ビニルピロリド/−酢酸ビニル共重合体(モ
ル比50ニア0)
(81N−ビニルピロリドン−酢酸ビニル共重合体(モ
ル比20 : 80 )
(9)N−ビニルピロリドン−プロピオン酸ビニル共重
合体(モル比60:40J
(till la−ビニルピロリドン−醋酸ビニル共
重合体(モル比70:50)
un n−ビニルピロリドン−アクリル酸メチル共重
合体(モル比95:5)
03)l−ビニルピロリドン−アクリル酸メチル共重合
体(モル比90:10)
(13N−ビニルピロリドン−アクリル酸メチル共重合
体(モル比75:25)
α荀 N−ビニルピロリドン−アクリル酸エチル共重合
体(モル比85:15)
tlj M−ビニルピロリドン−アクリル酸−n −
ブチル共重合体(モル比90:10’)(lb) N
−ビニルピロリドン−メタクリル酸メチル共重合体(モ
ル比90:10)
(17) N−ビニルピロリドン−メタクリル酸エチ
ル共重合体(モル比80:20)
(18) N−ビニルピロリドン−メタクリル酸−n
−ブチル共重合体(モル比95:5)
(11N−ビニルピロリドン−アクリロニトリル共重合
体(モル比85:15)
(4) N−ビニルピロリド/−スチレン共重合体(モ
ル比90 : 10 )
?ρ N−ビニルビロリドンースチレノ共重合体(モル
比75:25)
に) N−ビニルピロリドン−スチレン共重合体(モル
比50 : 50 )
本発明に係る共重合体は、公知の重合法を用いて容易に
得ることができる。Internal copolymer (1111-vinylpyrrolidone-vinyl acetate copolymer (
Molar ratio 95:5) (2) N-vinylpyrrolidone-vinyl acetate copolymer (molar ratio 80:20) (3) N-vinylpyrrolidone-vinyl acetate copolymer (molar ratio 70:50) (4) N -Vinylpyrrolidone-vinyl acetate copolymer (molar ratio 60:40) (51kl-vinylpyrrolidone-vinyl acetate copolymer (
Molar ratio 50:50') (6) N-vinylpyrrolidone-vinyl acetate copolymer (molar ratio 40:60) (N-vinylpyrrolidone/vinyl acetate copolymer (molar ratio 50:0) Pyrrolidone-vinyl acetate copolymer (molar ratio 20:80) (9) N-vinylpyrrolidone-vinyl propionate copolymer (mole ratio 60:40J (till la-vinylpyrrolidone-vinyl acetate copolymer (molar ratio 70) :50) un n-vinylpyrrolidone-methyl acrylate copolymer (molar ratio 95:5) 03) l-vinylpyrrolidone-methyl acrylate copolymer (molar ratio 90:10) (13N-vinylpyrrolidone-acrylic acid Methyl copolymer (molar ratio 75:25) αXun N-vinylpyrrolidone-ethyl acrylate copolymer (molar ratio 85:15) tlj M-vinylpyrrolidone-acrylic acid-n -
Butyl copolymer (molar ratio 90:10') (lb) N
-Vinylpyrrolidone-methyl methacrylate copolymer (molar ratio 90:10) (17) N-vinylpyrrolidone-ethyl methacrylate copolymer (molar ratio 80:20) (18) N-vinylpyrrolidone-methacrylic acid-n
-Butyl copolymer (molar ratio 95:5) (11N-vinylpyrrolidone-acrylonitrile copolymer (molar ratio 85:15)) (4) N-vinylpyrrolid/-styrene copolymer (molar ratio 90:10) ?ρ N-vinylpyrrolidone-styrene copolymer (molar ratio 75:25) N-vinylpyrrolidone-styrene copolymer (molar ratio 50:50) The copolymer according to the present invention can be produced by a known polymerization method. can be easily obtained using
なお、本発明に係る共重合体を中間層に用いる場合、前
記一般式lにおいてrl、xは50〜95モル優、yは
5〜50モル僑が好ましい。In addition, when the copolymer according to the present invention is used in the intermediate layer, in the general formula 1, rl and x are preferably 50 to 95 moles or more, and y is preferably 5 to 50 moles.
一般式■においては、xlは70〜95モル暢、ylは
5〜30モル僑が好ましい。また、展開層に含有する場
合、一般式!においては、Xは20〜50モル係、yは
50〜80モル俤が好ましく、一般式■においては、X
、は50〜70モル%%7.は30〜50モル優が好ま
しい。In the general formula (2), xl is preferably 70 to 95 moles, and yl is preferably 5 to 30 moles. Also, if it is contained in the developing layer, the general formula! In formula (2), X is preferably 20 to 50 mol, and y is 50 to 80 mol.
, is 50 to 70 mol%%7. is preferably 30 to 50 moles.
上記共重合体から成る層は、所望に応じて任意に選択す
ることが可能であるが、好ましくは[11〜50μm
更に好ましくはα5〜30μmである。また、上記共
重合体から成る層には、場合によっては前述の試薬類を
含有することもできる。The layer made of the above copolymer can be arbitrarily selected as desired, but preferably [11 to 50 μm]
More preferably α5 to 30 μm. Further, the layer made of the above-mentioned copolymer may optionally contain the above-mentioned reagents.
上記共重合体は、エタノール、プロノくノール、ブタノ
ール等のアルコール類、アセトン、メチルエチルケトン
等のケトン類、テトラヒドロフラン、トルエン、キシレ
ン、クロロホルム、ジクロロエタン等の有機溶媒に溶解
して塗設することができる。The above-mentioned copolymer can be coated by dissolving it in alcohols such as ethanol, pronophenol and butanol, ketones such as acetone and methyl ethyl ketone, and organic solvents such as tetrahydrofuran, toluene, xylene, chloroform and dichloroethane.
本発明の分析素子に係る支持体(以下、本発明に係る支
持体と略す)は、液体不浸透性で、かつ光透過性であれ
ばその種類を問わないが、例えば酢酸セルロース、ポリ
エチレンテレフタレート、ポリカーボネート又はポリス
チレンのような種々の重合体材料がこの使用目的に適す
る。更には上記重合体材料のみならず、ガラスのごとき
無機材料も同様に用いることが可能である。本発明に係
る支持体の厚さは任意であるが、好ましくは50〜25
0μmである。また、本発明に係る支持体の観測側の一
側面は、その目的に応じて任意に加工することが可能で
ある。The support related to the analytical element of the present invention (hereinafter abbreviated as the support related to the present invention) may be of any type as long as it is liquid-impermeable and light-transmissive, but for example, cellulose acetate, polyethylene terephthalate, Various polymeric materials are suitable for this purpose, such as polycarbonate or polystyrene. Furthermore, in addition to the above polymer materials, inorganic materials such as glass can be used as well. The thickness of the support according to the present invention is arbitrary, but preferably 50 to 25
It is 0 μm. Further, one side surface of the observation side of the support according to the present invention can be arbitrarily processed depending on the purpose.
更に試薬層を積層する側の支持体面に、場合によっては
光透過性の下塗り層を使用して試薬と支持体との接着性
を改良することができる。Furthermore, it is possible to improve the adhesion between the reagent and the support by using a light-transmitting undercoat layer on the side of the support on which the reagent layer is laminated, depending on the case.
本発明の分析素子は必要に応じで、例えば米国特許第4
992.158号明細書記載の反射層、下塗り層、米国
特許第4,042,535号明細書記載の放射線ブロッ
キング層、米国特許第4,06 &405号明細書記載
のバリヤー層、米国特許第4,166.093号明細書
記載のマイグレーション阻止層、特開昭55−9085
9号明細曹記載のヌカベンジャ−膚、及び米国特許第4
.11α079号明細書記載の破壊性ボンド状部材等を
任意に組合せて本発明の目的に合せた任意の構成とする
ことができる。The analytical element of the present invention may be used as required, for example, in US Pat.
Reflective layers as described in US Pat. No. 992.158, subbing layers, radiation blocking layers as described in US Pat. No. 4,042,535, barrier layers as described in US Pat. No. 4,06 & 405, US Pat. , 166.093, JP-A-55-9085
Nucavenger skin described in No. 9 and U.S. Patent No. 4
.. The destructible bond-like members described in No. 11α079 can be arbitrarily combined to form an arbitrary structure that meets the purpose of the present invention.
これら分析素子の種々の層は、本発明に係る支持体上に
所望の構成に従い、従来写真工業において公知のスライ
ドホッパー塗布法、押出し塗布法、浸漬塗布法等を適宜
選択して用い、順次積層することで任意の厚みの層を塗
設することができる。The various layers of these analytical elements are sequentially laminated on the support according to the present invention using a slide hopper coating method, an extrusion coating method, a dip coating method, etc., which are conventionally known in the photographic industry, and are appropriately selected according to the desired configuration. By doing so, a layer of arbitrary thickness can be applied.
本発明の分析素子を用いて、流体試料中の特定成分のt
t1本発明に係る支持体側から反射ヌペクトロフオトメ
トリーにより初速変法又は反応終点法に従って測定する
ことができる。このようにして得られた測定値は、あら
かじめ作成しておいた検量線に当てはめることで特定成
分の量を決定することができる。Using the analytical element of the present invention, t of a specific component in a fluid sample can be measured.
t1 It can be measured from the support side according to the present invention by reflection spectrophotometry according to a modified initial velocity method or a reaction end point method. The amount of the specific component can be determined by applying the measured value thus obtained to a calibration curve prepared in advance.
本発明の分析素子に適用される流体試料の量は任意に定
めることができるが、好ましくは約5μtから約50μ
tであシ、更に好ましくは5μtから20μLである。The amount of fluid sample applied to the analytical element of the present invention can be determined arbitrarily, but is preferably about 5 μt to about 50 μt.
It is preferably 5 μt to 20 μL.
通常10μtの流体試#1rt−適用するのが好ましい
。Usually 10 μt of fluid test #1 rt- is preferably applied.
本発明の分析素子は全血液、血清及び血漿のいずれの分
析にも不都合なく用いることができる。更には尿、リン
パ液、髄液等の他の体液も不都合なく用いられる。全血
液を用いる場曾には、必要に応じて検出のための放射線
が血球によシ妨害を受けるのを避けるために、前述の放
射線ブロッキング層又は他の反射層を設けることができ
る。The analytical element of the present invention can be used for the analysis of whole blood, serum, and plasma without any disadvantage. Furthermore, other body fluids such as urine, lymph, spinal fluid, etc. may be used without any disadvantage. In cases where whole blood is used, a radiation blocking layer as described above or other reflective layer may be provided, if necessary, to prevent radiation for detection from being interfered with by blood cells.
本発明の分析素子に用いられる分析反応は、その目的に
より任意に定めることができるが、例えば臨床化学の分
野に有用であシ、特に生物学的液体試料、すなわち血液
又は尿中の成分の分析に用いられる。The analytical reaction used in the analytical element of the present invention can be arbitrarily determined depending on the purpose, but it is useful, for example, in the field of clinical chemistry, and is particularly useful for analyzing components of biological fluid samples, such as blood or urine. used for.
なお、本発明の分析素子において、展開層と中間層に用
いる共重合体は同一でも異なっていてもよいが、同種の
方が、接着性をより強固にすることができる点で好適で
ある。In addition, in the analytical element of the present invention, the copolymers used for the spreading layer and the intermediate layer may be the same or different, but it is preferable that the copolymers be of the same type because they can make the adhesiveness stronger.
以下、実施列を挙げて本発明を更に具体的に説明するが
、本発明はこれらの実施例に限定されるものではない。Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
実施ff1J−1(HDL−コレステロール用多層分析
素子)
膜厚180μmの透明な下引済ポリエチレンテレフタレ
ート支持体上に下記組成の試薬層を設けた。Implementation ff1J-1 (Multilayer analytical element for HDL-cholesterol) A reagent layer having the following composition was provided on a transparent subbed polyethylene terephthalate support having a film thickness of 180 μm.
試薬層(R−1−1)
ゼラチy IAOf7wI”7−
クロロ−3−(2−へキシルデ
シルスルホニルエチル)−6−メ
チル−ビラゾロ[42−cコー8
一トリアゾール
ペルオキシダーゼ
アスコルビン酸オキシダーゼ
トリイングロビルナフタレンヌルホ
ン酸ナトリウム
?、2−上2−ビニルスルホニルエタ
ン)
フタル酸ジブチル
アジ化ナトリウム
M−2−ヒドロキシエチルピペラジ
ン−N′−2−エタンスルホン酸
中間層(Z)
1.89t/m”
1500007m”
9500 [7/m”
&56 f 7m”
α201/m”
t029/m”
α161/m”
4.0097m”
展開層(8)
FJfE原材料用繊維
スチレン−グリシジルメタクリレ
ート共jt@体(重置比9:1)
ポリオキシエチレンラウリルエーテル
コレステロールオキシターセ
コレヌテロールエステラーゼ
塩酸4−kl、M’−ジエチルアミノ
−2(2’−メタンスルホンアミ
ドエテル)アニリン 01897m”
ウシ血清アルブミン 五〇697m”91.0
W/m”
22.8f/m”
1五Of/m2
18000/m”
180007m”
展開層
表−1
上記組成のほかに下記の例示共重合体を含有する展開層
を調製し、上記試薬層上に、上表の中間層及び下表の展
開層を順次設け、表−1に示す本発明の分析素子−1〜
6並びに比較分析素子−1及び2を作成した。Reagent layer (R-1-1) Gelatiny IAOf7wI”7-
Chloro-3-(2-hexyldecylsulfonylethyl)-6-methyl-virazolo[42-c-8 monotriazole peroxidase ascorbic acid oxidase triingrovir naphthalene sodium sulfonate? , 2-vinylsulfonylethane) Sodium dibutyl azide phthalate M-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid intermediate layer (Z) 1.89t/m"1500007m" 9500 [7/m"&56 f 7m"α201/m"t029/m"α161/m"4.0097m" Spreading layer (8) FJfE raw material fiber styrene-glycidyl methacrylate cojt@body (overlapping ratio 9:1) Polyoxyethylene lauryl ether Cholesterol oxitasecholene terol esterase hydrochloride 4-kl, M'-diethylamino-2(2'-methanesulfonamide ether)aniline 01897m"
Bovine serum albumin 50,697m”91.0
W/m" 22.8 f/m" 15Of/m2 18000/m" 180007 m" Developing layer table-1 In addition to the above composition, a developing layer containing the following exemplified copolymer was prepared, and a spreading layer was placed on the reagent layer. The intermediate layer shown in the upper table and the development layer shown in the lower table were sequentially provided to the analytical elements-1 to 1 of the present invention shown in Table-1.
6 and comparative analysis elements-1 and 2 were prepared.
上記本発明の分析素子−1〜6並びに比較分析素子−1
及び2に各゛橿HDL−コレステロール濃度のヒト血清
を10μL点着し、57℃で7分間インキュベーション
を行った後、546nmのフィルターを用いて反射濃度
を測定し、この[耐浸11:ユニキツ) HDL−コレ
ステロール−N〔中外製薬(株)製〕で検定したヒト血
清のEDL−コレステロール濃度値から、あらかじめ検
量線を作成した。The above analytical elements-1 to 6 of the present invention and comparative analytical element-1
10 μL of human serum with a HDL-cholesterol concentration was applied to each column of HDL and 2, and after incubation at 57°C for 7 minutes, the reflection density was measured using a 546 nm filter. A calibration curve was prepared in advance from the EDL-cholesterol concentration values of human serum assayed with -Cholesterol-N (manufactured by Chugai Pharmaceutical Co., Ltd.).
更にヒト血清の中から正常値(50q/dt )及び異
常値(25xq/dt )のものを各々10回点着し、
上記と同様の操作を行い反射濃度を測定し、あらかじめ
作成した検量線に当てはめてHD、L−コレステロール
濃度値を算出した後、変動係数CVSを求めた。結果を
表−2に示す。Furthermore, human serum with normal value (50q/dt) and abnormal value (25xq/dt) was spotted 10 times each.
The same operation as above was performed to measure the reflection density, and the HD and L-cholesterol concentration values were calculated by applying it to a calibration curve prepared in advance, and then the coefficient of variation CVS was determined. The results are shown in Table-2.
宍−2
表−2の結果から明らかなように、本発明の分析素子−
1〜6は、比較分析素子−1及び2に比し、良好な同時
再現性を示すことが判る。Shishi-2 As is clear from the results in Table-2, the analytical element of the present invention-
It can be seen that Samples Nos. 1 to 6 exhibit better simultaneous reproducibility than Comparative Analysis Elements-1 and 2.
なお、比較分析素子−1及び2では、分析素子(スライ
ド)を作成するため、小片に断裁する際に、試薬層と展
開層の間でrtはく離が認められたが本発明の分析素子
−1〜6では全くはく離が認められず良好な接着性を示
した。特に本発明の分析素子−5ri良好な接着性を示
し、かつ同時再現性も良好な結果を得た。In addition, in Comparative Analytical Elements-1 and 2, rt peeling was observed between the reagent layer and the developing layer when cutting into small pieces to prepare analytical elements (slides), but in Analytical Element-1 of the present invention, rt peeling was observed between the reagent layer and the developing layer. In samples 6 to 6, no peeling was observed and good adhesion was exhibited. In particular, the analytical element-5ri of the present invention exhibited good adhesion and good simultaneous reproducibility.
以上説明したように、本発明の分析素子では試薬層と多
孔性展開層の間の接着性が著しく改善され、それに伴っ
て測定精度(同時再現性)も大幅に改善されるという顕
著な効果が奏せられる。As explained above, the analytical element of the present invention has the remarkable effect that the adhesion between the reagent layer and the porous spreading layer is significantly improved, and the measurement accuracy (simultaneous reproducibility) is also significantly improved accordingly. It can be played.
Claims (1)
する流体試料中の特定成分を分析するための多層分析素
子において、下記一般式 I 及びII: ▲数式、化学式、表等があります▼・・・[ I ] 〔式中、R_1は低級アルキル基、xは20〜95モル
%、yは5〜80モル%なる数を示す〕 ▲数式、化学式、表等があります▼・・・[II] 〔式中、R_2は水素原子又はメチル基、R_3はフェ
ニル基、シアノ基又は式−COOR_4で表わされる基
(式中R_4は低級アルキル基を示す)、x_1は50
〜95モル%、y_1は5〜50モル%なる数を示す〕 で表わされる共重合体よりなる群から選択した少なくと
も1種の共重合体を、前記多孔性展開層、及び前記試薬
層と前記多孔性展開層との間の層に含有していることを
特徴とする多層分析素子。[Claims] 1. A multilayer analytical element for analyzing a specific component in a fluid sample having a reagent layer on a support and a porous spreading layer above the reagent layer, which has the following general formulas I and II: ▲Math. There are chemical formulas, tables, etc. ▼... [I] [In the formula, R_1 is a lower alkyl group, x is a number from 20 to 95 mol%, and y is a number from 5 to 80 mol%] ▲ Numerical formulas, chemical formulas, tables, etc. ▼... [II] [In the formula, R_2 is a hydrogen atom or a methyl group, R_3 is a phenyl group, a cyano group, or a group represented by the formula -COOR_4 (in the formula, R_4 represents a lower alkyl group), x_1 is a 50
~95 mol%, y_1 represents a number of 5 to 50 mol%] At least one copolymer selected from the group consisting of copolymers represented by: A multilayer analytical element characterized in that the content is contained in a layer between the porous spreading layer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20728288A JPH0255954A (en) | 1988-08-23 | 1988-08-23 | Multilayered analysis element |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20728288A JPH0255954A (en) | 1988-08-23 | 1988-08-23 | Multilayered analysis element |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0255954A true JPH0255954A (en) | 1990-02-26 |
Family
ID=16537217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20728288A Pending JPH0255954A (en) | 1988-08-23 | 1988-08-23 | Multilayered analysis element |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0255954A (en) |
-
1988
- 1988-08-23 JP JP20728288A patent/JPH0255954A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0726959B2 (en) | Whole blood analysis element | |
US4990457A (en) | Whole blood dry analysis element | |
JPH0219908B2 (en) | ||
JPS63259467A (en) | Integration type multi-layer analysis element for determining ammonia product | |
JPH0431677B2 (en) | ||
JP2546981B2 (en) | Multilayer analysis element | |
US4567024A (en) | Analytical element | |
JPH029310B2 (en) | ||
JPH0255954A (en) | Multilayered analysis element | |
JPH02208565A (en) | Method and device for separating plasma from blood and analyzing element used for said method | |
JPH05268996A (en) | Dry analytical element for assaying salicylate | |
JPH02181656A (en) | Total cholesterol analyzing element | |
JPS6353465A (en) | Analyzing element | |
JPS63158000A (en) | Integrated multi-layer analytic element for quantitative determination of total cholesterol | |
CN114002422B (en) | Multi-layer membrane dry chemical reagent tablet for biochemical analysis | |
JPS5988097A (en) | Analytical element | |
JPH02167446A (en) | Analysis of liquid sample | |
JPH025897A (en) | Multi-layer analytical element for determination of gamma-glutamyl transpeptidase activity | |
JPH02102455A (en) | Measuring element | |
JPS6352897A (en) | Analytic element | |
JPS63249053A (en) | Dry analytical element | |
US7105128B2 (en) | Dry analytical element using water-soluble indicator for colorimetry | |
JPH0373818B2 (en) | ||
JPH0219905B2 (en) | ||
JPS61262660A (en) | Analytical element |